Page 226 - Pagetit
P. 226

6. CONCURRENT DISORDERS



                     Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review
                     of supporting evidence. American Journal of Psychiatry, 122:509–522.
                     Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in
                     schizophrenia: patterns of drug choice. Journal of Nervous and Mental Disorders,
                     175:641–652.
                     Schuckit MA (1985) The clinical implications of primary diagnostic groups among
                     alcoholics. Archives of General Psychiatry, 42:1043–1049.
                     Schuckit MA (1994) Alcohol and depression: a clinical perspective.  Acta
                     Psychiatrica Scandinavica, 377:28–32.
                     Schuckit MA et al. (1997a) Comparison of induced and independent major
                     depressive disorders in 2,945 alcoholics. American Journal of Psychiatry, 154:948–
                     957.
                     Schuckit MA et al. (1997b) The life-time rates of three major mood disorders and
                     four major anxiety disorders in alcoholics and controls. Addiction, 92:1289–1304.
                     Self DW (1998) Neural substrates of drug craving and relapse in drug addiction.
                     Annals of Medicine, 30:379–389.
                     Sevy S et al. (1990) Significance of cocaine history in schizophrenia. Journal of
                     Nervous and Mental Disorders, 178:642–648.
                     Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of
                     abstinence. Psychopharmacology, 50:35–39.
                     Shoaib M, Stolerman IP (1992) MK801 attenuates behavioural adaptation to
                     chronic nicotine administration in rats. British Journal of Pharmacology, 105:514–
                     515.
                     Shopsin B, Friedman E, Gershon S (1976) Parachlorophenylalanine reversal of
                     tranylcypromine effects in depressed patients. Archives of General Psychiatry,
                     33:811–819.
                     Shopsin B et al. (1975) Use of synthesis inhibitors in defining a role for biogenic
                     amines during imipramine treatment in depressed patients. Psychopharmacology
                     Communications, 1:239–249.
                     Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist.
                     Journal of Pharmacology and Experimental Therapeutics, 295:321–327.
                     Smith JA et al. (1995) Cocaine increases extraneuronal levels of aspartate and
                     glutamate in the nucleus accumbens. Brain Research, 683:264–269.
                     Snyder SH (1976) Dopamine and schizophrenia. Psychiatric Annals, 6:53–64.
                     Snyder SH (1980) Phencyclidine. Nature, 285:355–356.
                     Soni SD, Brownlee M (1991) Alcohol abuse in chronic schizophrenics:
                     implications for management in the community. Acta Psychiatrica Scandinavica,
                     84:272–276.
                     Sorg BA, Kalivas PW (1993) Effects of cocaine and footshock stress on extracellular
                     dopamine levels in the medial prefrontal cortex. Neuroscience, 53:695–703.
                     Soyka M (1994) Alcohol dependence and schizophrenia: what are the
                     interrelationships? Alcohol and Alcoholism, Suppl 2: S473–S478.


                                                     205




          Chapter_6                205                             19.1.2004, 11:49
   221   222   223   224   225   226   227   228   229   230   231